Capital Insights
The ‘Banknote’ Blueprint: Halocell’s Plan to Print the Next Solar Revolution
Beyond rooftops—Halocell Energy’s “banknote” printing creates highly efficient, flexible, lightweight, recyclable and cost-effective solar cells for shaded areas and from dawn to dusk, detailing the three-horizon plan.
The Iron Chaperone: Alterity’s High-Stakes Sprint on Brain Iron Redistribution
Multiple System Atrophy (MSA) is a devastating neurological disease with no known cure. Alterity Therapeutics is breaking the “black box” of MSA with ATH434, a first-in-class drug that targets toxic iron accumulation. After successful Phase 2 results, the company is now scaling for a pivotal Phase 3 trial, positioning itself as a frontrunner in a multi-billion dollar orphan drug market.
What is a Wholesale Investor in Australia? Complete 2026 Guide
What is a Wholesale Investor in Australia? A wholesale investor is an individual or entity that meets specific financial thresholds set out in the Corporations Act 2001 (Cth), qualifying them to access investment opportunities that are not available to general retail investors. These include private equity rounds, venture capital deals, pre-IPO placements, alternative funds, and […]
Why the 20-Year Hold Is the Secret to Australian Life Sciences Returns
Australia represents 0.3% of the world’s population. Yet it generates more than 3% of global research output. Cochlear implants. Wi-Fi. The HPV vaccine. These are not statistical anomalies. They are proof points of a structural advantage that Australia has failed to capitalise on. The country has a world-class research base. But it watches companies scale […]
The ‘Unused Billion’: How Points4Purpose is Disrupting the Flatlining Loyalty Market
The loyalty industry is plagued by “sameness,” leaving billions in value dormant. Ivan Schwartz’s Points4Purpose is disrupting this flatlining market by turning rewards into a liquid currency for rent, bills, and over 1.8 million charities.
1,000km, sustainable, efficient , no onboard pilot: How ‘Gap Drone ’ is rewriting the rules of remote logistics
Can autonomous drones solve Australia’s “tyranny of distance”? GAP Drone CEO Liesl Haris thinks so. With the launch of ATLAS—an autonomous transport logistics aircraft system—the company is bypassing traditional infrastructure to deliver 50kg payloads over 1,000km. Dubbed the “Uber of airfreight,” GAP Drone is tackling the “too hard basket” of remote logistics, partnering with Australia Post to provide First Nations communities and regional hubs with reliable, low-cost access to medicine, food, and economic opportunity. By operating within current regulatory frameworks and utilising a “no-runway” launch model, GAP Drone is transforming air freight from an expensive luxury into a scalable utility.
Precision Care, Zero Clicks: Why the Future of the NDIS is Voice-First
Carelogix is solving the healthcare burnout crisis by replacing manual typing with a sophisticated AI “care co-pilot.” By reclaiming nearly half of a caregiver’s day, the platform offers a significant value inflection point for providers and investors in the trillion-dollar care economy.
The Private Equity Signal I Am Watching Very Closely
Pattern recognition in private markets is not about predicting the future. It is about reading what is already moving before the wider market notices. I spotted the same signal in life sciences 18 months before it became consensus. We are watching it happen again, this time in private equity.
The Australian Life Science Sector: A Structural Convergence of 5 Critical Factors
For a decade, we have watched the foundation being built. Government grants are flowing into research infrastructure. Labs constructed. IP portfolios are growing. Talent returning from global pharma. For most of that decade, the returns were slow, the timelines were long, and the capital was cautious. That era is over. The Australian life science sector […]
Backed By Leading Investment Groups and Family Offices
